Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPD | P32754 | 3/20 | 0.60 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.59 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.59 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.59 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.59 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | FLT1 | P17948 | 1/20 | 0.55 |
| ▸ | FLT4 | P35916 | 1/20 | 0.55 |
| ▸ | KDR | P35968 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | TTR | P02766 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28953061 | 0.98 | HPD (0.59) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 | |
| Hydrochloric Acid SCHEMBL11776053 | 0.98 | HPD (0.59) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL22749348 | 0.91 | ALDH1A1 (0.72) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 | |
| Piperidine SCHEMBL3903114 | 0.88 | HPD (0.56) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL6224986 | 0.88 | AKR1B1 (0.51) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL8492000 | 0.87 | MAPT (0.49) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL8942455 | 0.87 | MAPT (0.49) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL16031334 | 0.87 | TTR (0.64) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL5452045 | 0.87 | HPD (0.60) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 | |
| SCHEMBL4658862 | 0.85 | HPD (0.62) | HPDAKR1B1AKR1C4AKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4642921-A1 | METHODS OF IDENTIFYING, IMAGING, AND CHARACTERIZING BACTERIAL SPORES USING LANTHANIDE-BETA-DIKETONES | Temasek Life Sciences Laboratory Limited (SG) | 2025-11-05 | — | — | EP | claimed |
| EP-4642865-A1 | BACTERIAL SPORES AS GREEN AND EFFICIENT BIOLOGICAL-INORGANIC HYBRID PHOSPHORS | Temasek Life Sciences Laboratory Limited (SG) | 2025-11-05 | — | — | EP | claimed |
| US-12308860-B2 | Apparatus for mitigating nonlinearity-induced spurs and noise in a fractional-N frequency synthesizer | UNIVERSITY COLLEGE DUBLIN (IE) | 2025-05-20 | — | — | US | claimed |
| CN-115850082-B | Preparation method of 2-nitro-4-trifluoromethyl benzoic acid | 内蒙古蓝科生物科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119757578-A | Detection method and preparation method of nitenpyram impurity | 安徽贝克制药股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-116640063-B | Preparation method of nitenpyram | 安徽贝克制药股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119176768-A | Preparation method and application of catechol derivatives and administration and preparation device | 海南大学 | 2024-12-24 | — | — | CN | claimed |
| CN-113221408-B | Model reduced-order calculation method based on ABAQUS parallel NTFA theory | 浙江工业大学 | 2024-09-27 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-4868333-A | Production of 2-nitro-4-trifluoromethylbenzoic acid | ICI AMERICAS INC. (US) | 1989-09-19 | — | — | US | claimed |
| US-4845279-A | Method of preparing 4-trifluoromethyl-2-nitrobenzoic acid and novel isomer | CENTRAL GLASS COMPANY, LIMITED (JP) | 1989-07-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | HPD 1124/4885AKR1B1 1963/4885AKR1C4 1502/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | HPD 40/4885AKR1B1 2784/4885AKR1C4 2258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.